Insights from the dabigatran versus warfarin trial in patients with venous
thromboembolism (the RE-COVER trial).
Author(s): Prandoni P, Taher A.
Affiliation(s): University of Padua, Department of Cardiothoracic and Vascular Sciences,
Thromboembolism Unit, Via Giustiniani 2, 35128 Padua, Italy. paoloprandoni@tin.it
Publication date & source: 2010, Expert Opin Pharmacother. , 11(6):1035-7
In this clinical trial evaluation, we revisit the RE-COVER study, a large
multicenter, randomized, double-blind, noninferiority trial on patients with
acute venous thromboembolism treated with dabigatran versus warfarin. Study
design and key results are re-evaluated in the context of previous work and
future perspectives.
|
